Premium
Exploring the binding site of the human muscarinic M3 receptor: Homology modeling and docking study
Author(s) -
Ostopovici Liliana,
Mracec Maria,
Mracec Mircea,
Borota Ana
Publication year - 2007
Publication title -
international journal of quantum chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 105
eISSN - 1097-461X
pISSN - 0020-7608
DOI - 10.1002/qua.21290
Subject(s) - docking (animal) , chemistry , homology modeling , ramachandran plot , protein data bank (rcsb pdb) , stereochemistry , rhodopsin , autodock , hydrogen bond , agonist , molecular model , binding site , crystallography , protein structure , receptor , molecule , biochemistry , in silico , medicine , retinal , nursing , organic chemistry , gene , enzyme
The human muscarinic M3 receptor (hM3) and its interactions with selective agonists and antagonists were investigated by means of combined homology and docking approach. Also, two pharmacophoric models for the hM3 agonist and antagonist binding sites were proposed. The three‐dimensional (3D) structure of hM3 receptor was modeled based on the high‐resolution X‐ray structure of bovine rhodopsin from the Protein Data Bank (PDB). To validate the reliability of the model obtained, the main chain torsion angles phi (Ψ) and psi (Φ) were examined in a Ramachandran plot, and all omega angles were measured for peptidic bond planarity. The characteristics of the active site, the position, and the orientation of ligands in situ, as well as the binding modes of the representative agonists and antagonists, were analyzed by applying a molecular docking technique using the AutoDock 3.0.5 program. Specific interactions responsible for recognition of the hM3 receptor, like ionic bond formed between protonated amine of the ligands and the Asp3.6 side chain were identified. Structure–reactivity relationships have been explained by analyzing the 3D structure of the hM3 model and the ligand conformations resulted from molecular docking simulation. © 2007 Wiley Periodicals, Inc. Int J Quantum Chem, 2007